Episodes

Sunday Nov 17, 2024
RheumNow Day 1 Recap ACR Convergence 2024 Highlights
Sunday Nov 17, 2024
Sunday Nov 17, 2024
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.
Join us live and stay at the forefront of rheumatology!

Saturday Nov 16, 2024
ACR24 - Day1c
Saturday Nov 16, 2024
Saturday Nov 16, 2024
Aging Gracefully in Managing Rheumatic Diseases:Dr. Mrinalini Dey interviews Dr. Elena Myasoedova
Apremilast Benefits and Risks in PsA:Dr. Akhil Sood
Assessing ASAS Criteria: CLASSIC Study Results:Dr. Adela Castro
Assessment and management of axSpA:Dr. Antoni Chan
Disease Activity in RA-ILD:Dr. Richard Conway
Finding the Right Combination Therapy in RA:Dr. Jonathan Kay interviews Dr. Ernest Choy
Highlights in axSpA:Dr. Marina Magrey
Hot Topics in axSpA:Dr. Marina Magrey
Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis:Dr.
Antoni Chan interviews Dr. Catherine Bakewell
PsA Potpourri:Dr. Arthur Kavanaugh
RA Treatment Adherence: Is decision making really shared?:Dr. Jonathan
Kay interviews Dr. Cécile Gaujoux-Viala
RA: One JAK to Rule Them All?:Dr. Brian Jaros
What is a Positive MRI in Spondyloarthritis?:Dr. Sheila Reyes interviews Dr. Walter Maksymowych

Saturday Nov 16, 2024
ACR24 - Day1b
Saturday Nov 16, 2024
Saturday Nov 16, 2024
JAK-pot! How fast do DMARDs work?:Dr. Mike Putman and Dr. Kim Lauper
Paraoxonase-1: Possible Biomarker for Progression to RA:Dr. Jonathan Kay
Potential Impact of Weight Loss Drugs in Rheumatic Diseases:Dr. Arthur Kavanaugh
PREDICT-SpA: Evaluating the influence of gender on disease assessment tools:Dr. Sheila Reyes
SELECT-GCA: Upadacitinib in Giant Cell Arteritis:Dr. Mike Putman
Too Many CAR-Ts for Horses?:Dr. Pope
Transplant-free Survival Predictors in Idiopathic Inflammatory Myopathies-ILD:Dr. Gaby Martinez

Saturday Nov 16, 2024
ACR2024 - Day1a
Saturday Nov 16, 2024
Saturday Nov 16, 2024
A New ACR:Dr. Cush
Are we under-monitoring in scleroderma ILD?:Dr. Janet Pope
Cancer Survival in RA:Dr. Eric Dein interviews Joshua Hsieh
Continuing or Stopping Low Dose Glucocorticoids in GPA:Dr. Mike Putman
COVID Associated Immune Disease:Dr. Len Calabrese
How to Master ACR Meetings:Dr. Cush

Friday Nov 15, 2024
ACR 2024 Preview Podcast (11.15.2024)
Friday Nov 15, 2024
Friday Nov 15, 2024
ACR 2024 starts tomorrow; here are a few previews of Abstracts to be presented. Along with my recommendations of sessions you don’t want to miss.

Friday Nov 08, 2024
Dr. Quotes (11.8.2024)
Friday Nov 08, 2024
Friday Nov 08, 2024
Dr. Jack Cush reviews the news and journal reports from this past week from RheumNow.com

Monday Nov 04, 2024
Monday Nov 04, 2024
Minimizing steroid use in patients with SLE. Learn more about when, why, and how to taper steroids and listen to experts, Dr Michelle Petri and Dr Leanna Wise, discuss key data and their clinical perspectives on these topics.

Friday Nov 01, 2024
Happy Diwali (11.1.2024)
Friday Nov 01, 2024
Friday Nov 01, 2024
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

Friday Oct 25, 2024
Blue Collar Arthritis (10.25.2024)
Friday Oct 25, 2024
Friday Oct 25, 2024
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com
Register now for RheumNow.live 2025

Wednesday Oct 23, 2024
EMJ Podcast Interview with Dr. Jack Cush
Wednesday Oct 23, 2024
Wednesday Oct 23, 2024
This week, Jonathan is joined by John J Cush, from Dallas, Texas, USA. The two doctors explore novel treatment avenues for rheumatic diseases, and discuss the exciting potential of AI and telemedicine.